• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name:  Methotrexate
Date Designated:  08/28/2014
Orphan Designation:  Treatment of Myasthenia Gravis
Orphan Designation Status:  Designated
FDA Orphan Approval Status:  Not FDA Approved for Orphan Indication
The Universtiy of Kanasa Medical Center
3901 Rainbow Blvd
MSN 2012
Kanasa City, Kansas 66160
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.